Valneva SE
VALN
NASDAQ·Healthcare·Biotechnology·Mkt cap $653.3M
$6.89
▼ -2.41%
P/E
-3.25
Mkt Cap
$653.3M
52-Wk Range
$4.75–$12.23
52-Week Range
$4.75 - $12.23
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 19.1% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Average volatility.
Growth
Mild headwinds expected
Value
Deep value opportunity - significant discount to sector peers
Momentum
Hot
+25.7% over 3m
Quality
Thin
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying VALN right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 19, 2026
AUG 13, 2026
Reported EPS of -$0.40 vs -$0.19 consensus (-112.1% surprise). Revenue of $40.3M vs $44.2M expected (-8.8%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-112.1%
Revenue trend · last 8Q
—
—
—
—
-36%
-10%
-38%
-27%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$53.5M
$61.8M
$57.5M
$56.4M
$34.3M
$55.7M
$35.8M
$41.5M
Margins · last 8Q
Profit
-89.3%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: TD Cowen · Aug 11, 2026
vs Industry
How VALN stacks vs Biotechnology
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.